Description of original award (Fiscal Year 2022, $658,931)
This submission falls under Category 2 Enhancement.
There are approximately 25,431 residents in Peekskill, New York. However, that number does not reflect the undocumented population. As of 2020, the demographics of Peekskill were as follow: 39.3% White, 23.1% Black or African American, 44.1% Hispanic or Latino, 2.0% Asian, and 9.0% who are two or more races. Females make up 52.3% of the population while males make up 47.7%. Peekskill is in the Northern part of Westchester and is considered an urban jurisdiction.
The funds are being requested for the enhancement of the Peekskill City Drug Treatment Court (PCDTC) which handles misdemeanor cases. The target goal of participants whom we expect to provide services to under this project is 40.
The program is post-adjudication.
The PCDTC is a Type 1 Adult Drug Court.
The Peekskill City Court is located at 2 Nelson Avenue, Peekskill, NY, 10566.
The designated drug court Judge is Hon. Reginald J. Johnson, and his number is (914) 831-6485. The Resource Coordinator’s contact information is (914) 831-6469.
We are requesting $658,931 for the life of the grant.
The total number of participants proposed to receive services with these grants funds is 40. The minimum length of program participation is 6 months; the maximum length of participation is 1 year; the average length of participation is 12 – 18 months.
The target population of the PCDTC is high-risk/high-need and low-risk/low-need.
Participants have access to a plethora of MAT services through various treatment providers and physicians.
PCDTC provides a continuum of care for substance abuse treatment including residential, intensive outpatient and outpatient treatment, and recovery support services which are utilized to address opioid, stimulant, and substance abuse.
It is affirmed that the NADCP Adult Best Practices will be addressed (pages 2, 3, 4, 6, 12, and 13).
The PCDTC is not leveraging any other federal funding sources to support the program.
The PCDTC received a BJA Drug Court implementation grant in 2018 (grant number 2018-DC-BX-0132).